NanoBio Corporation Closes $11 Million Series C Financing
11/28/2012 8:19:31 AM
More...
|
NanoBio Corporation Announces Data Presentation on Its Nanoemulsion Adjuvanted RSV Vaccine at IDWeek 2012
10/15/2012 10:08:05 AM
More...
|
NanoBio Corporation Promotes David Peralta to Chief Executive Officer
10/9/2012 8:28:16 AM
More...
|
NanoBio Corporation to Report Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium
9/24/2012 10:03:04 AM
More...
|
NanoBio Corporation to Present Preclinical Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine and Novel Inhaled Cystic Fibrosis Therapy at 52nd Annual ICAAC Meeting
9/10/2012 9:15:25 AM
More...
|
NanoBio Corporation to Collaborate in Research Effort for Respiratory Syncytial Virus Vaccine With Merck & Co., Inc. (MRK)
12/8/2011 9:34:40 AM
More...
|
NanoBio Corporation Secures Novel Antigen Source Through National Institutes of Health (NIH) for its Intranasal RSV Vaccine
8/3/2011 9:48:31 AM
More...
|
NanoBio Corporation Announces Publication of Study Results For Intranasal Nanoemulsion-Adjuvanted Vaccine
7/21/2011 7:18:15 AM
More...
|
NanoBio Corporation Announces First Patients Vaccinated in Phase 1b Intranasal Influenza Vaccine Study
6/21/2011 9:24:54 AM
More...
|
George Arida Named to NanoBio Corporation Board of Directors
6/14/2011 9:37:06 AM
More...
|
|